abstract |
The present invention relates to a quantitative combination of phytate and zinc in synergistic proportions for use in the treatment of hydroxyapatite crystallization. Advantageously, the combination is a phytate and zinc molar ratio of greater than 4: 1. The invention also relates to the use of the combination for the manufacture of a medicament for use in the treatment, prevention and / or avoidance of crystallization of hydroxyapatite in humans. |